However, other studies that investigated the same NOD2 SNPs in transplant patients and corresponding donors could not confirm their effect on GVHD pathogenesis (52), or showed an increased risk of relapse and death if recipients and/or donors were carrying such an alteration in the NOD2 gene (62, 63). Here, NOD2 is linked to graft versus host disease.